Home » All » Stock Forecast » Passage Bio Inc. Common Stock Forecast

Passage Bio Inc. Common Stock Forecasts for Tomorrow, Week, Month and 5 Years

Updated: April 22 · 2026 at 07:03 UTC

From

▼ -1.12%Market Cap $19.82M · Technical analysis Bearish · Focus area Price + volatility

Forecast Summary

Timeframe	Predicted Price	Past	Historical	Insight
Tomorrow	$6.13 ▼ -0.80%	Yesterday	$6.20 ▲ +0.33%	Tomorrow's Passage Bio Inc. Common Stock (PASG) setup is anchored to $6.18 and targets $6.13 (-0.80%). The near-term read is downside; watch $6.37 / $5.99 because daily realized volatility is about 4.10%.
Tomorrow's Passage Bio Inc. Common Stock (PASG) setup is anchored to $6.18 and targets $6.13 (-0.80%). The near-term read is downside; watch $6.37 / $5.99 because daily realized volatility is about 4.10%.
Week	$6.03 ▼ -2.48%	Last Week	$6.24 ▲ +1.04%	The 7-day Passage Bio Inc. Common Stock model moves from $6.24 to $6.03 (-2.48%). It gives downside momentum context for this stock, so breaks around $6.37 / $5.99 matter more than a single tick.
The 7-day Passage Bio Inc. Common Stock model moves from $6.24 to $6.03 (-2.48%). It gives downside momentum context for this stock, so breaks around $6.37 / $5.99 matter more than a single tick.
Month	$5.85 ▼ -5.27%	Last Month	$6.32 ▲ +2.21%	The 1-month Passage Bio Inc. Common Stock target is $5.85 (-5.27%), compared with the live reference near $6.18. This horizon blends current trend pressure with price momentum, liquidity, and company-specific risk.
The 1-month Passage Bio Inc. Common Stock target is $5.85 (-5.27%), compared with the live reference near $6.18. This horizon blends current trend pressure with price momentum, liquidity, and company-specific risk.
Year	$5.60 ▼ -9.46%	Last Year	$6.43 ▲ +3.97%	The 1-year Passage Bio Inc. Common Stock scenario points to $5.60 (-9.46%). Confidence is lower than short-term rows, so treat it as cycle context and re-check it after major market-data updates.
The 1-year Passage Bio Inc. Common Stock scenario points to $5.60 (-9.46%). Confidence is lower than short-term rows, so treat it as cycle context and re-check it after major market-data updates.
5 Years	$4.99 ▼ -19.29%	5 Years Ago	$6.68 ▲ +8.10%	The 5-year Passage Bio Inc. Common Stock view is $4.99 (-19.29%). It is a directional scenario built from bounded drift and volatility, not a guaranteed path.
The 5-year Passage Bio Inc. Common Stock view is $4.99 (-19.29%). It is a directional scenario built from bounded drift and volatility, not a guaranteed path.

Tomorrow$6.13▼ -0.80%

Yesterday$6.20▲ +0.33%

Tomorrow's Passage Bio Inc. Common Stock (PASG) setup is anchored to $6.18 and targets $6.13 (-0.80%). The near-term read is downside; watch $6.37 / $5.99 because daily realized volatility is about 4.10%.

Week$6.03▼ -2.48%

Last Week$6.24▲ +1.04%

The 7-day Passage Bio Inc. Common Stock model moves from $6.24 to $6.03 (-2.48%). It gives downside momentum context for this stock, so breaks around $6.37 / $5.99 matter more than a single tick.

Month$5.85▼ -5.27%

Last Month$6.32▲ +2.21%

The 1-month Passage Bio Inc. Common Stock target is $5.85 (-5.27%), compared with the live reference near $6.18. This horizon blends current trend pressure with price momentum, liquidity, and company-specific risk.

Year$5.60▼ -9.46%

Last Year$6.43▲ +3.97%

The 1-year Passage Bio Inc. Common Stock scenario points to $5.60 (-9.46%). Confidence is lower than short-term rows, so treat it as cycle context and re-check it after major market-data updates.

5 Years$4.99▼ -19.29%

5 Years Ago$6.68▲ +8.10%

The 5-year Passage Bio Inc. Common Stock view is $4.99 (-19.29%). It is a directional scenario built from bounded drift and volatility, not a guaranteed path.

Risk notice:This forecast is informational only, not financial advice; accuracy depends on volatility, liquidity, macro events, and other external factors.

Price Chart

HistoricalForecastBullishBearish

Technical Analysis

Bearish

Bullish

Neutral

Bearish

Key Indicators

Indicator	Value	Signal
Price	$6.18	Mid
Daily Change	-1.12%	Below
Volatility Cap	20.0%	Mid
Confidence	59%	Below
Data Source	nasdaq-screener	Mid

Historical Data

Current$6.18

Daily Change-1.12%

Market Cap$19.82M

Sourcenasdaq-screener

Current	$6.18	Daily Change	-1.12%
Market Cap	$19.82M	Source	nasdaq-screener

Support & Resistance Levels

$5.99Support 1

$6.18Current

$6.37Resistance 1

Support and resistance are estimated from the trusted current price until deeper historical data is available.

Price Milestones

Key levels & historical context

Current$6.18Live reference price

Used as the anchor for generated forecast calculations.

Next Month$5.85Model projection-5.27%

Directional scenario based on capped drift.

Forecast Accuracy

How our model has performed

59%

Directional

Generated market-data forecast

This page uses live catalog market data and conservative volatility caps. It is informational, not financial advice.

📊

Our algorithm is re-calibrated weekly using the latest price action, volatility regime, and indicator signals. Accuracy varies by timeframe — short-term momentum is more reliable than long-term projections.

Short term

59%

Direction confidence

Long term

Lower

Forecast uncertainty rises with horizon

Investment Scenarios

If you invest $1,000 in PASG today

Bullish Scenario

$6.49

+5.00% from current

Target Price$6.49

ScenarioUpside momentum

Probability51%

Base Scenario

$5.85

-5.27%

Target Price$5.85

ScenarioCapped drift

Probability59%

Bearish Scenario

$5.87

-5.00% from current

Target Price$5.87

ScenarioVolatility drawdown

Probability41%

Basis: Scenario model combines current spot price, recent market direction, and conservative asset-class volatility caps.

Forecast Factors

Market Structure

Price structure reflects the latest momentum regime and support/resistance interaction.

Momentum Bearish · 39/100

24H drift-0.80%

7D drift-2.48%

30D drift-5.27%

Technical Signals

Signals combine RSI, MACD, and moving average stacks to estimate short-term direction.

Mixed — Watching · 50/100

RSIn/a

MACDn/a

MA stackn/a

Macro Context

Rates, dollar strength, and cross-asset risk appetite influence medium-term paths.

Risk-Off Caution · 33/100

1M outlook-5.27%

1Y outlook-9.46%

5Y outlook-19.29%

Frequently Asked Questions

Q What is the Passage Bio Inc. Common Stock (PASG) forecast for tomorrow?

Using the latest BeCoin market snapshot (April 22 · 2026 at 07:03 UTC), Passage Bio Inc. Common Stock is projected near $6.13 versus the current reference around $6.18. That implies a modeled move of -0.80% over the next day, with realized prices still sensitive to intraday volatility.

Q What does the 7-day stock outlook suggest for PASG?

The weekly Passage Bio Inc. Common Stock model points to $6.03, which maps to an expected drift of -2.48% from current conditions. This horizon reacts quickly to momentum shifts, so support/resistance breaks can change the path faster than long-term targets.

Q How should I read the Passage Bio Inc. Common Stock 1-month and 1-year targets?

The Passage Bio Inc. Common Stock 1-month target is $5.85 (-5.27%), while the 1-year target is $5.60 (-9.46%). The monthly view tracks prevailing trend pressure, and the yearly view reflects broader cycle assumptions shaped by price momentum, liquidity, and company-specific risk.

Q Why does the Passage Bio Inc. Common Stock 5-year scenario differ from short-term rows?

The Passage Bio Inc. Common Stock long-horizon scenario sits near $4.99 with a modeled change of -19.29%. It compounds cycle-continuation assumptions over time, so it should be treated as a scenario envelope rather than a precise endpoint.

Q Where are PASG support and resistance zones right now?

For Passage Bio Inc. Common Stock, nearest resistance is around $5.99, while nearest support is around $6.37. A clean break above resistance improves continuation odds, while repeated closes under support raise downside risk.

Q How fresh is the Passage Bio Inc. Common Stock market snapshot?

The displayed stock snapshot is labeled April 22 · 2026 at 07:03 UTC; the latest observed session range is roughly n/a to n/a. These checkpoints are rebuilt from the market feed so the FAQ, milestones, and support/resistance context stay tied to the same data refresh.